期刊文献+

nm23-H2基因抑制卵巢癌细胞侵袭转移及调节网络初探 被引量:2

Research of function and gene regulation network of invasion and metastasis related nm23-H2 gene of epithelial ovarian cancers
下载PDF
导出
摘要 目的研究上皮性卵巢癌转移相关nm23-H2基因功能及其调控网络,为最终揭示卵巢癌侵袭转移分子机制和晚期卵巢癌基因治疗提供理论依据。方法将nm23-H2重组质粒pCDNA3/nm23-H2转染人卵巢癌细胞系SKOV3.ip1,经G418抗性筛选及RT-PCR鉴定得到稳定转染阳性克隆H2-18,设计体外黏附实验及人工基底膜侵袭实验比较转染前后细胞黏附侵袭特性的改变。应用2 747点人类肿瘤相关Oligo芯片检测转染前后细胞基因表达的改变,寻找与nm23-H2相关下游调控肿瘤相关基因,并探讨其调节网络。结果用重组质粒pCDNA3/nm23-H2转染SKOV3.ip1细胞。转染前后细胞在体外的增殖能力没有显著变化,转染后细胞的黏附与侵袭基底膜能力明显降低。经人类肿瘤相关Oligo芯片检测转染前后细胞发现55个二倍差异表达基因,在上调基因中以转录调节、信号转导、分化发育及细胞凋亡类基因为多;下调基因中以信号传导及黏附运动功能类基因为主。结论nm23-H2基因具有抑制卵巢癌侵袭转移的作用,并且这一作用的实现是通过对一系列下游肿瘤相关基因的调控来完成的。基因芯片技术结合普通分子生物学技术是后基因组时代肿瘤相关基因功能研究及探索基因调控网络的有效手段。 Objective To investigate the function and gene regulation network of invasion and metastasis related nm23-H2 gene of epithelial ovarian cancer,with the hope of providing theory basis for the molecular mechanism of ovarian cancer invasion and metastasis,and seeking for a new approach of gene function study in postgenome era.Methods Epithelial ovarian cancer cells SKOV3.ip1 were transfected with human recombinant plasmid pCDNA3/nm23-H2.The stable transfected clone H2-18 with G418 resistance was further confirmed by RT-PCR of the nm23-H2 gene expression.The adhesion and invasion ability to basilar membrane was compared between H2-18 and vector-alone transfected C2.And human cancer Oligo chip with 2 747 genes was used to explore the relevant down-streaming genes and the gene regulation network of nm23-H2.Results The adhesion and invasion ability to basilar membrane of H2-18 was reduced compared with vector-alone transfected clone C2,while the multiplication capacity unchanged.The expression of 55 genes was found changed after nm23-H2 transfection.According to the gene function category,they mainly belong to the categories of transcription regulation,signal transduction,adhesion and motility and differentiation.Conclusions Nm23-H2 gene can be a metastasis inhibitor of epithelial ovarian cancer through regulations of other down-streaming genes.Microarray combined with bioinformatics methods is an effective way for gene function research in postgenome era.
出处 《中国妇产科临床杂志》 2009年第6期445-448,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 卵巢癌 基因转染 基因芯片 NM23-H2 调控网络 epithelial ovarian cancer gene transfection microarray nm23-H2 gene regulation network
  • 相关文献

参考文献7

  • 1Steeg PS, Bevilaqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastasis potential. J Natl Cancer Inst, 1988, 80.- 200- 204.
  • 2Leone A, Flatow U, Van Houtte K, et al. Transfection of human nm23 - H2 into the human MDA - MB- 435 breast carcinoma cell line: effects on tumor metastatic potential, colonization, and enzymatic activity. Oncogene, 1993, 8: 2325 - 2333.
  • 3Howlett AR, Peterson OW, Steeg PS, et al. A novel function for nm23: overexpression in human breast carcinoarna ceils leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst, 1994, 86:1838 - 1844.
  • 4Stahl JA, Leone A, Rosengard AM, et al. Identification of a second human nm23 gene, nm23 - H2. Cancer Res, 1991, 51: 445-449.
  • 5白符,冯捷,石菁菁,成夜霞,杨蓉,崔恒.具有不同转移潜力的卵巢癌细胞系基因表达谱的比较研究[J].现代妇产科进展,2005,14(3):181-185. 被引量:3
  • 6Hidetaka M, Mitsugu F, Yasushi I, et al. Overexpression of nm23- H2/NDP Kinase B in a Human Oral Squamous Cell Line Results in Reduced Metastasis, Differentiation Phenotype in the Metastatic Site, and Growth Factor- independent Proliferative Activity in Culture. Clinical Cancer Research, 1999, 5: 4301-4307.
  • 7Bettina S, Rolf A, Michael H, et al. Alterations of the metastasis suppressor gene nm23 and the proto - oneogene c - myc in human testicular germ cell tumors. The Journal of Urology, 1997, 158.. 2000-2005.

二级参考文献7

  • 1Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray [J]. Science, 1995,270,467 - 470.
  • 2Yu DH,Judith KW,Scanlon M ,et al. Enhanced c-erbB-2/ neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A [J]. Cancer Res, 1993,53 : 891 - 898.
  • 3Albini A,Iwamoto Y,Kleinman HK,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells [J]. Cancer Res, 1987,47 : 3239-3245.
  • 4Lancaster JM, Dressman HK, Whitaker RS, et al. Gene expression patterns that characterize advanced stage serous ovarian cancers [J]. J Soc Gynecol Investig, 2004,11, 51-59.
  • 5Cossins J, Dudgeon TJ, Catlin G, et al. Identification of MMP18,a putative novel human matrix metalloproteinase [J]. Biochem Biophys Res Commun, 1996,228 : 494 - 498.
  • 6Li Qz, Eckenrode S, Ruan QG, et al. Rapid decrease ofRNA levels of a novel mouse mitochondria solute carrier protein(MSCP) gene at 4-5 weeks of age [J]. MammGenome. 2001 , 12:830 - 836.
  • 7Stahl JA, Leone A, Ariella RM, et al. identitication of a second human nm 23 gene, nm23-H2 [J]. Cancer Res,1991,51:445-449.

共引文献2

同被引文献35

  • 1侯振江.基因标志物在肺癌预后监测中的应用[J].临床肺科杂志,2004,9(6):668-669. 被引量:3
  • 2张丽华,侯振江.nm23基因在肿瘤预后监测中的应用[J].中国肿瘤临床与康复,2006,13(1):85-88. 被引量:9
  • 3Havrilesky L,Darcy M,Hamdan H. Prognostic significiane of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer:a Gynecologic Oncology Group Study[J].Journal of Clinical Oncology,2003,(20):3814-3825.
  • 4Hogdall EV,Christensen L,Hogdall CK. Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas[J].Acta Pathologica,Microbiologica Et Immunologica Scandinavica,2008,(05):400-409.
  • 5Kupryjanczyk J,Szymanska T,Madry R. Evaluation of clinical significance of TP53,BCL-2,BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen[J].British Journal of Cancer,2003,(06):848-854.
  • 6Yasui K,Mihara S,Zhao C. Alteration in copy numbers genes as a mechanism for acquired drug resistance[J].Cancer Research,2004,(04):1403-1410.
  • 7Liguang Z,Peishu L,Hongluan M. Survivin expression in ovarian carcinoma[J].Eep Oncol,2007,(02):121-125.
  • 8Takai N,Miyazaki T,Nishida M. Expression of survivin isassociated with malignant potrntial in epithelial ovarian carcinoma[J].International Journal of Molecular Medicine,2002,(02):211-216.
  • 9Liguang Z,Peishu L,Hongluan M. Survivin expression in ovarian cancer[J].Experimental Oncology,2007,(02):121-125.
  • 10Gilbert L,Basso O,Sampalis J. Assessment of symptomatic women for early diagnosis of ovarian cancer:results from the prospective DOvE pilot project[J].Lancet Oncology,2012,(13):285-291.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部